Monthly Archives: January 2020
Chronic pain is a common and often debilitating problem that can significantly impact function and quality of life for patients with spinal cord injury.
To help find treatment solutions, UBC researchers are investigating the effectiveness of a drug called Targin at treating chronic pain in individuals with spinal cord injury. The research team is now recruiting study participants.
The Dealhack Persons With Disabilities Discounts Guide is a list of stores and brands that offer discounts for persons with psychological, psychiatric, or cognitive disabilities. Every three months, we update the lists to include the newest offers to help you save on your purchases.
The list currently consists of more than 80 stores and services divided into 19 categories. It can be saved in PDF format and used as the ultimate savings guide for persons with disabilities.
Potential First-in-Class Therapy for Chronic Spinal Cord Injury
NEW HAVEN, Conn., Jan. 08, 2020 (GLOBE NEWSWIRE) — ReNetX Bio announced today that the U.S. Food and Drug Administration (FDA) has granted the company Fast Track Designation for ReNetX Bio’s clinical therapy (AXER-204) for the potential treatment of Chronic Spinal Cord Injury (SCI). ReNetX Bio is currently conducting a Phase 1/2 clinical trial “RESET” in patients with SCI, with topline results expected in 2021.
Implanting an infusion pump that continuously delivers the muscle relaxant baclofen to the spinal canal is a safe and effective treatment for muscle stiffness in people with neurological conditions, including cerebral palsy (CP), and provides a great degree of satisfaction to patients, according to 19 years of clinical experience at a single center in Portugal.
Columbia engineers invent a robotic trunk-support-trainer to retrain patients with spinal cord injury to sit more stably and gain an expanded active sitting workspace